A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this ...

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%. Further complicating treatment, standard therapies ...

First patient in fifth cohort exhibiting stable disease 90 days after treatment. Multiple patients surviving more than one year, including one beyond two years, with no dose-limit ...

Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to ...

Medically reviewed byJimmy Almond, M.D. Ovarian cancer is the result of abnormal cell growth that forms a tumor in the ovaries or fallopian tubes. It is the second most prevalent gynecologic cancer in ...

Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI ...

An interdisciplinary team of UCLA scientists is working to create a therapy designed to both eliminate cancer cells and dismantle the tumor’s protective defenses, reducing the likelihood of recurrence ...

HALIFAX, Nova Scotia, May 04, 2026 (GLOBE NEWSWIRE)-- To mark World Ovarian Cancer Day, Ovarian Cancer Canada is announcing a $725,000 investment to fuel critical ovarian cancer research. Led by ...

Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop resistance to conventional therapies quickly. Despite aggressive ...

Immediate consultation with a fertility specialist is crucial for ovarian cancer patients to explore fertility preservation options before treatment begins. Advances in assisted reproductive ...

Ovarian cancer can be a difficult-to-detect disease early on because its symptoms often are vague and easily mistaken. Here ...

After months of advocacy and negotiations, a breakthrough for ovarian cancer patients. A specialized chemotherapy treatment ...